Abstract
New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Current Pharmaceutical Design
Title:Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review
Volume: 23 Issue: 36
Author(s): Jean-Claude Alvarez*, Nicolas Fabresse and Islam A. Larabi
Affiliation:
- Department of Pharmacology and Toxicology, Versailles Saint-Quentin-en-Yvelines University, Inserm U-1173, Raymond Poincare hospital, AP-HP, Garches,France
Keywords: New psychoactive substances, designer drugs, bath salts, hair, alternative biological matrix, prevalence, mass spectrometry, synthetic cathinones.
Abstract: New psychoactive substances (NPS) have emerged in a threatening way in the last decades. They are sold via the internet or head shops with several names (bath salts, Research chemical, RCs, Legal Highs) and forms (pills, tablets, powder...etc.), and are labelled ambiguously to escape governmental legislation. Designer drugs belong to different chemical classes, but cathinones derivatives presented the most prevalent group. In 2013, this group accounted for 30% of NPS seizures in Europe with more than 450 different compounds, including 101 new molecules reported for the first time in 2014. The increased number of NPS as being sold in parallel market has led several countries to adopt different strategies either on individual surveillance of new emerging drugs or more efficiently on generic control regrouping a wide number of isomers and structurally similar compounds. The identification of these substances is a challenge for toxicologists, which requires sensitive and specific analytical methods based on LC-MS/MS or GC-MS. The usefulness of hair as an alternative matrix for prevalence studies was proved since it offers an overview on drug exposure with a large detection window over weeks or even months and years according to the length of the hair strand. However, as for many drugs of abuse, prevalence studies on cathinones derivatives use are still scarce. Self-reported use or case reports provide most of the available data.
The aim of this paper is to provide an update review on prevalence and surveillance of synthetic cathinones use conducted by hair analysis, excluding case report.
Export Options
About this article
Cite this article as:
Alvarez Jean-Claude*, Fabresse Nicolas and Larabi A. Islam , Prevalence and Surveillance of Synthetic Cathinones Use by Hair Analysis: An Update Review, Current Pharmaceutical Design 2017; 23 (36) . https://dx.doi.org/10.2174/1381612823666170704124156
DOI https://dx.doi.org/10.2174/1381612823666170704124156 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Combination Treatment with rt-PA is More Effective than rt-PA Alone in an in Vitro Human Clot Model
Current Neurovascular Research Endothelial Dysfunction and Coronary Artery Spasm
Current Drug Targets - Cardiovascular & Hematological Disorders Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity
Current Medicinal Chemistry Pain and Inflammation
Current Medicinal Chemistry Characterization of HBV Among HBV/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya
Current HIV Research Investigation of Cytotoxic Effects of Oxymetazoline on Lungs in a Rat Model of Rhinitis Medicamentosa
Current Molecular Pharmacology Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science Meet Our Editorial Board Member
Mini-Reviews in Medicinal Chemistry Potential of Alphavirus Vectors in the Treatment of Advanced Solid Tumors
Recent Patents on Anti-Cancer Drug Discovery Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences
Current Neuropharmacology Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers
Current Medical Imaging Neuropharmacological Screening of Chiral and Non-chiral Phthalimide- Containing Compounds in Mice: in vivo and in silico Experiments
Medicinal Chemistry Anti-Inflammatory Activity of Novel 12-N-methylcytisine Derivatives
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
Current Gene Therapy Preface: Scope of Current Alzheimer Research Debomoy
Current Alzheimer Research Editorial [Hot topic: MDMA (Ecstasy) Toxicity: Pharmacokinetic, Metabolism, Cell Response and Pathological Consequences (Guest Editor: Vittorio Fineschi)]
Current Pharmaceutical Biotechnology Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer’s Disease
Current Protein & Peptide Science Vasoactive Factors and Diabetic Retinopathy: Vascular Endothelial Growth Factor, Cycoloxygenase-2 and Nitric Oxide
Current Pharmaceutical Design Unraveling the Dopamine Receptor Signalplex by DRIPs and DRAPs
Current Proteomics